3BP-4961

N/A

Report date: 2025/11/14 09:32:39

Base Information

Drug Name3BP-4961

Drug Alias Name3BP-4961SPECTROFAP99mTc-3BP-4961

ClassificationDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Nuclides > Technetium > 99mTcRadiation-emitting products > Radioactive diagnostic agent +[4]

Mechanisms of ActionFibroblast activation protein alpha modulators

TargetsProlyl endopeptidase FAP

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustraliaGermany

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator Companies3B Pharmaceuticals GmbH

China Registration ClassN/A

Develop Information

Active Companies3B Pharmaceuticals GmbH

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A